Financials
- Market Capitalization 3.23 B
- Employee 145
- Founded 2015
- CEO N/A
- Website www.ideayabio.com
- Headquarter Delaware, United States
- FIGI BBG00CTZ4D83
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-21.22
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 1618 | DYN Dyne Therapeutics, Inc. - Common Stock | 23.99 USD | +0.88% | +1.01% | +30.88% | +2.48% | 3.43 B USD | ||
| 1650 | ELVN Enliven Therapeutics, Inc. - Common Stock | 53.16 USD | +2.76% | +4.38% | +24.94% | +157.31% | 3.24 B USD | ||
| 1664 | BEAM Beam Therapeutics Inc. - Common Stock | 30.84 USD | -0.16% | -15.81% | -0.68% | +53.28% | 3.17 B USD | ||
| 1680 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 31.71 USD | -1.00% | -8.64% | +26.39% | +15.90% | 3.12 B USD |